Which MSAs will see bidding first? The durable medical equipment industry has fought to give input on the Medicare competitive bidding process, and it was input they were asked for - and lots of it - at the most recent Program Advisory and Oversight Committee meeting.
In addition to laying out the numerous questions, CMS and RTI conducted an overview of other bidding programs conducted by the Department of Veterans Affairs, Utah and Minnesota.
The Centers for Medicare & Medicaid Services is in the very beginning stages of formulating the upcoming bidding system for DME. CMS aims to issue a proposed rule on the system next summer, with a final rule following in early summer 2006, staffers said in the Dec. 6 and 7 PAOC meeting in Baltimore, MD. Bidding implementation is set for January 2007.
Staffers from CMS and bidding contractor Research Triangle Institute came armed with a bevy of complicated questions for committee members. Here are the main issues touched on:
RTI floated a number of ideas for measuring the largest MSAs, including total population, Medicare fee-for-service population, and total charges for DME, prosthetics, orthotics and supplies. MSAs such as New York, Miami-Fort Lauderdale and Los Angeles seem like shoe-ins, while places such as Chicago, Philadelphia, Dallas-Fort Worth and Houston seem likely candidates.
Other considerations for choosing MSAs could include geographic size, the number of suppliers in the area, and whether the area crosses state lines and/or DME regional carrier lines, RTI suggested.
PAOC members were leery of choosing MSAs based on Medicare's previous two bidding demonstrations, reports committee member Cara Bachenheimer with Invacare Corp. CMS conducted the demos in much smaller MSAs, Bachenheimer notes on Inva-care's Web site.
Highest-cost and highest-volume items, as well as those with the largest savings potential, may be put up for bid first, MMA instructs. CMS can exempt items not expected to see significant savings under bidding, RTI noted. Also up for discussion was whether each MSA should have the same items subject to bidding.
Committee members urged CMS to convene "a PAOC meeting where clinicians, manufacturers, and consumer representatives could discuss how the equipment is used and the clinical factors that would determine whether a given item is suitable for competitive bidding," Bachenheimer says.
Editor's Note: The presentations from the meeting and other materials are at www.cms.hhs.gov/suppliers/dmepos/compbid/.